BABA vs TRIP

The Advanced Deterministic Scorecard reveals a mixed financial profile for Alibaba (BABA), with a weak Piotroski F-Score of 4/9 indicating suboptimal financial health, and no available Altman Z-Score limiting distress risk assessment. While valuation metrics appear favorable relative to peers—especially a Price/Sales of 0.41 and Forward P/E of 19.50—earnings growth is sharply negative (YoY EPS down 71%), and recent quarterly beats have reversed into consistent misses over the last four quarters. Strong insider sentiment and a bullish analyst consensus (strong_buy) contrast with deteriorating profitability and weak technical trends (10/100). The stock trades significantly above the Graham Number ($102.68) and intrinsic value estimate ($51.38), suggesting overvaluation unless growth rebounds materially.

TRIP presents a complex value trap profile, characterized by a stable but mediocre Piotroski F-Score of 4/9 and a significant valuation gap where the current price ($11.48) far exceeds both the Graham Number ($6.27) and the Intrinsic Value ($2.17). While the Forward P/E of 6.78 and a PEG of 0.20 suggest an attractive entry point based on future earnings expectations, these are offset by stagnant revenue growth (0.00%) and a high Debt/Equity ratio of 1.94. The long-term price performance is severely depressed (-77.2% over 5 years), and technicals remain bearish. Overall, the stock is a speculative play on a turnaround that is not yet supported by top-line growth.